ClinicalTrialsFinder
RecruitingNCT04464655

A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

2,130 participants

Start Date

Dec 12, 2019

Study Type

OBSERVATIONAL

Conditions

Hypertrophic CardiomyopathyCoronary Artery DiseaseCongenital Heart DiseaseMyocarditisDilated CardiomyopathyAortic Valve StenosisInfiltrative CardiomyopathyAortic Valve RegurgitationPericardial EffusionVascular Anomaly

Summary

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Healthy Volunteers
  • Age: \> 18y, Informed consent No known current or pre-existing significant medical conditions that would affect the cardiovascular or respiratory system
  • Age: \>18 y, Informed consent, Clinically indicated CMR exam

Exclusion Criteria4

  • General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.Regular nicotine consumption during the last 6 months
  • Patients
  • General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies Vasoactive medication (e.g. nitro) during the 12 hours prior to the exam. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.
  • Regular nicotine consumption during the last 6 months
Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

McGill University Health Center

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04464655

Related Trials

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT0719069012 locations

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

NCT04124120146 locations

A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy

NCT072411044 locations

Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease

NCT062590194 locations

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT0677963017 locations